We are live on ! Find out more
IFRX icon

InflaRx
IFRX

31 hedge funds and large institutions have $17.9M invested in InflaRx in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,650% more call options, than puts

Call options by funds: $175K | Put options by funds: $2K

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

4.02% more ownership

Funds ownership: 22.08% → 26.1% (+4%)

3% more funds holding

Funds holding: 30 → 31 (+1)

44% less capital invested

Capital invested by funds: $32.1M → $17.9M (-$14.2M)

Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
5
Closed
10
Calls
$175K
Puts
$2K
Net Calls
+$173K
Net Calls Change
-$241K

Top Buyers

Rank Fund Capital Flow
1
EP
Eversept Partners
New York
+$2.23M
2
SCM
Silverarc Capital Management
Massachusetts
+$2.19M
3
WP
Woodline Partners
California
+$1.42M
4
SCM
Suvretta Capital Management
New York
+$1.41M
5
SC
Stempoint Capital
New York
+$1.37M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$1.46M
2
UOC
UBS O'Connor
Illinois
-$1.07M
3
UBS Group
UBS Group
Switzerland
-$167K
4
Northern Trust
Northern Trust
Illinois
-$90.4K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$51.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Suvretta Capital Management
New York
$6.61M +$1.41M +750,000 +13%
6CM
2
683 Capital Management
New York
$2.68M +$1.05M +555,000 +27%
EP
3
Eversept Partners
New York
$1.71M +$2.23M +1,183,526 +240%
Morgan Stanley
4
Morgan Stanley
New York
$1.29M -$1.46M -776,514 -38%
SCM
5
Silverarc Capital Management
Massachusetts
$1.18M +$2.19M +1,161,567 New
WP
6
Woodline Partners
California
$766K +$1.42M +750,984 New
SC
7
Stempoint Capital
New York
$740K +$1.37M +725,019 New
Raymond James Financial
8
Raymond James Financial
Florida
$645K -$11.1K -5,888 -0.9%
Northern Trust
9
Northern Trust
Illinois
$631K -$90.4K -47,942 -7%
DCM
10
DAFNA Capital Management
California
$459K +$849K +450,000 New
Citadel Advisors
11
Citadel Advisors
Florida
$441K +$720K +381,908 +750%
BFM
12
Boothbay Fund Management
New York
$161K – – –
Commonwealth Equity Services
13
Commonwealth Equity Services
Massachusetts
$109K -$9.43K -5,000 -4%
FSA
14
Franklin Street Advisors
North Carolina
$77K – – –
UOC
15
UBS O'Connor
Illinois
$59.2K -$1.07M -567,516 -91%
Squarepoint
16
Squarepoint
New York
$54.6K +$79K +41,884 +360%
BC
17
Birchview Capital
Vermont
$51K – – –
Geode Capital Management
18
Geode Capital Management
Massachusetts
$49.1K – – –
XT
19
XTX Topco
Cayman Islands
$38.3K +$70.8K +37,528 New
CSS
20
Cubist Systematic Strategies
Connecticut
$30.7K +$14.4K +7,616 +34%
PP
21
Pacifica Partners
Canada
$21.8K – – –
BNP Paribas Financial Markets
22
BNP Paribas Financial Markets
France
$21.5K +$1.51K +800 +4%
QC
23
Quadrature Capital
United Kingdom
$14.4K +$26.1K +13,858 New
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$13.8K +$25.5K +13,538 New
HF
25
HRT Financial
New York
$10K +$20.2K +10,724 New
1
2

IFRX Hedge Fund Activity: Q1 2025 in Review

31 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q1 2025, worth a combined $17.9M — down 44% from $32.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new IFRX positions and 10 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Eversept Partners, adding an estimated $2.23M. The largest seller was Morgan Stanley, cutting an estimated $1.46M.

  • 31 institutional investors held InflaRx (IFRX) as of Q1 2025, up from 30 in Q4 2024.
  • Funds reported $17.9M of InflaRx stock for Q1 2025, down 44% quarter-over-quarter.
  • 11 funds opened new InflaRx positions in Q1 2025 and 10 closed out, a net change of +1 holder.
  • The largest InflaRx buyer in Q1 2025 was Eversept Partners, an estimated $2.23M added.
  • The largest InflaRx seller in Q1 2025 was Morgan Stanley, an estimated $1.46M sold.

Based on aggregated 13F filings for Q1 2025.